The U.S. Food and Drug Administration (FDA) has officially launched a new inspection initiative known as One-Day Inspectional Assessments (ODIAs), signaling an important shift in how FDA-regulated companies may be inspected moving into 2026 and beyond. For manufacturers, exporters, and FDA-regulated businesses supplying products to the United States, this development reflects the FDA’s growing focus… Continue reading FDA One-Day Inspectional Assessments: What FDA-Regulated Companies Need to Know in 2026